Renée joined Norwest in 2022 as an Operating Executive. As a member of the portfolio services team, she lends her 20+ years of B2B marketing experience to the portfolio, working shoulder-to-shoulder with company leaders to help them optimize and scale their revenue engines for growth.
Prior to joining Norwest, Renée was a senior vice president at Lucidworks where she set global strategy for brand, product marketing, demand gen, and sales development. Before Lucidworks, she was a practice area leader at Trellist, a marketing consultancy and agency. Starting her career in tech startups, Renée cultivated deep hands-on experience and strategic leadership in a range of marketing functions including marketing ops, demand gen, social, branding, and product marketing.
Renée holds a bachelor of arts double major in political science and history from the University of Massachusetts where she graduated with honors.
Ryan brings to Norwest Venture Partners more than thirty years of healthcare experience and twenty years as a growth equity and buyout investor. Combining deep medical knowledge and extensive strategic business experience, Ryan focuses on growth equity investments in the healthcare sector in Norwest’s Palo Alto office. Areas in which he invests include healthcare services, pharma services, healthcare IT, and medical products. Ryan’s current investments include American Endovascular, Blue Cloud, Elligo Health Research, Kyo (formerly Gateway Learning Group), Mindful Health Solutions, Onsite Dental, and Target RWE. His previous investments include Capsugel (acquired by Lonza), Crossover Health (acquired by Gurnet Point Capital), iCardiac (acquired by ERT), and Rivermend Health.
Prior to joining Norwest, Ryan was a Principal with The Carlyle Group and a Venture Partner with Industry Ventures, where he focused exclusively on healthcare services, pharmaceutical, and medical device investments from large cap buyouts to growth equity and venture.